J&J TVT NICE Guidance Suggests Cost Savings Over Colposuspension
This article was originally published in The Gray Sheet
Executive SummaryJohnson & Johnson/Ethicon Gynecare TVT tension-free vaginal tape "appears to be cost effective" relative to colposuspension for stress incontinence, according to a 1UK National Institute for Clinical Excellence technology appraisal guidance issued Feb. 26
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.